Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$13.10 USD
-0.46 (-3.39%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $13.11 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Income Statements
Fiscal Year end for ORTHOFIX MEDICAL INC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 747 | 461 | 464 | 407 | 460 |
Cost Of Goods | 260 | 124 | 115 | 102 | 101 |
Gross Profit | 486 | 337 | 350 | 305 | 359 |
Selling & Adminstrative & Depr. & Amort Expenses | 625 | 350 | 358 | 311 | 378 |
Income After Depreciation & Amortization | -139 | -13 | -8 | -6 | -19 |
Non-Operating Income | -1 | -3 | -3 | 8 | -8 |
Interest Expense | 9 | 1 | 2 | 2 | 0 |
Pretax Income | -149 | -18 | -14 | 0 | -27 |
Income Taxes | 3 | 2 | 25 | -3 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -151 | -20 | -38 | 3 | -28 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -151 | -20 | -38 | 3 | -28 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -43 | 19 | 37 | 28 | 10 |
Depreciation & Amortization (Cash Flow) | 97 | 32 | 45 | 34 | 28 |
Income After Depreciation & Amortization | -139 | -13 | -8 | -6 | -19 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 36.70 | 20.10 | 19.69 | 19.39 | 18.90 |
Diluted EPS Before Non-Recurring Items | -4.12 | 0.30 | 0.86 | 0.26 | 1.47 |
Diluted Net EPS (GAAP) | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 |
Fiscal Year end for ORTHOFIX MEDICAL INC falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 200.42 | 184.01 | 187.02 | 175.20 |
Cost Of Goods | NA | 63.79 | 64.24 | 67.47 | 64.88 |
Gross Profit | NA | 136.63 | 119.76 | 119.55 | 110.33 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 154.94 | 144.21 | 156.18 | 170.05 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -18.31 | -24.45 | -36.63 | -59.72 |
Non-Operating Income | NA | 0.77 | -2.36 | -0.02 | 0.68 |
Interest Expense | NA | 4.50 | 1.58 | 1.27 | 1.29 |
Pretax Income | NA | -22.05 | -28.39 | -37.92 | -60.33 |
Income Taxes | NA | 0.12 | 0.47 | 1.51 | 0.61 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -22.17 | -28.86 | -39.43 | -60.94 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -22.17 | -28.86 | -39.43 | -60.94 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 37.30 | 37.20 | 36.80 | 35.70 |
Diluted EPS Before Non-Recurring Items | NA | -0.59 | -0.77 | 0.02 | -0.47 |
Diluted Net EPS (GAAP) | NA | -0.57 | -0.77 | -1.07 | -1.71 |